Vargeese Chandra
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Vargeese Chandra. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| WVE | See Remarks | Option Exercise | 91,754 | $2.48 | $227,550 | Mar 4, 2025 |
| WVE | See Remarks | Award / Grant | 37,000 | — | — | Feb 4, 2025 |
| WVE | See Remarks | Option Exercise | 46,000 | $2.48 | $114,080 | Jan 23, 2025 |
| WVE | See Remarks | Option Exercise | 68,210 | $2.48 | $169,161 | Jul 22, 2024 |
| WVE | See Remarks | Sale | 10,249 | $4.03 | $41,303 | Feb 16, 2023 |
| WVE | See Remarks | Sale | 16,714 | $1.72 | $28,748 | May 4, 2022 |
| WVE | Chief Technology Officer | Sale | 10,603 | $2.32 | $24,599 | Feb 16, 2022 |
| WVE | Chief Technology Officer | Sale | 3,145 | $10.57 | $33,243 | Feb 1, 2021 |
| WVE | Senior VP, Drug Discovery | Sale | 3,188 | $7.85 | $25,026 | Feb 18, 2020 |
| WVE | Senior VP, Drug Discovery | Sale | 6,000 | $35.00 | $210,000 | Dec 3, 2019 |
| WVE | Senior VP, Drug Discovery | Award / Grant | 15,000 | — | — | Mar 7, 2019 |
| WVE | Senior VP, Drug Discovery | Sale | 2,055 | $36.84 | $75,706 | Feb 19, 2019 |
| WVE | Senior VP, Drug Discovery | Option Exercise | 3,000 | $2.48 | $7,440 | Sep 24, 2018 |
| WVE | See Remarks | Option Exercise | 2,000 | $2.48 | $4,960 | Feb 15, 2018 |
| WVE | See Remarks | Option Exercise | 2,000 | $2.48 | $4,960 | Jan 23, 2018 |
| WVE | See Remarks | Option Exercise | 1,500 | $2.48 | $3,720 | Nov 22, 2017 |
| WVE | See Remarks | Award / Grant | 9,800 | — | — | Jan 25, 2017 |